Mortality remains high among patients with pulmonary arterial hypertension awaiting lung transplant, despite changes to the allocation system that were designed to reduce mortality and increase the equitable distribution of donor organs, according to new research out of University of California San Francisco. The study is reported in the September 1 issue of the American Journal of Respiratory and Critical Care Medicine, published by the American Thoracic Society. Until just a few years ago, the amount of time that a given patient had been on the waiting list was the only factor in determining his or her priority, but in 2005, a new allocation system based on a "lung allocation score" (LAS), was implemented.
Two of the most powerful approaches to cancer treatment -- a stem cell transplant and an immune system-stimulating vaccine -- appear to reinforce each other in patients with an aggressive, hard-to-control form of leukemia, Dana-Farber Cancer Institute scientists have found. In a study to be published in the online early edition of the Proceedings of the National Academy of Sciences the week of Aug. 24, the researchers report that patients with high-risk acute myeloid leukemia (AML) or advanced myelodysplasia (a blood disorder) who received a cancer vaccine shortly after a stem cell transplant not only had few complications but also mounted a strong immune system attack on the disease.
Researchers Report On Function, Cosmetic Appearance, And Adverse Events Following Hand Transplantation
In a special issue dedicated to prosthetics research, researchers at the Christine Kleinert Institute for Hand and Microsurgery in Louisville, Kentucky, provide an update on five patients to receive hand transplants in the United States. The update describes a brief history of each patient, why they were transplanted, the immunosuppression they received and complications they encountered, and a summary of how each patient is functioning with their new hand. Based on these findings, researchers conclude that hand transplants are not only feasible but a clinical option for select patients. Hand transplantation promises patients function and sensation that they could not achieve with a prosthesis.
BMA Cymru Wales estimates around 30 people have died in Wales in the last year, waiting for a transplant on the organ donor register. The leading doctors' union is now calling for action to be taken by the Welsh Assembly Government with regard to possible changes to the organ donation system. It's also a year since the Assembly's Health Committee rejected any ideas to change the organ donation system in Wales. This led to the Welsh Assembly Government's wider consultation on the matter, which has just closed. BMA Cymru Wales submitted a response to this consultation, reiterating calls for a "soft" system of presumed consent to be introduced and to do so sooner rather than later, before more lives are lost.
Tony Huesman, who survived with a single transplanted heart longer than any other transplant patient, died Aug. 9 at his home in Washington Township, Ohio. Huesman received his heart in August 1978 at Stanford Hospital & Clinics, one of the early beneficiaries of the hospital's heart transplant program. He died of complications from cancer, said his wife, Carol Huesman. He was 51. "His heart held up to the end, " she said. A native of Dayton, Ohio, Huesman was diagnosed while in high school with cardiomyopathy, a disease that progressively weakens the heart. He attended Miami University in Ohio, but dropped out because of his illness.
Transform, the largest cosmetic surgery in the UK, has announced the launch of the UK's first ever eyelash transplant, allowing women and men with complete or partial eyelash loss to regain their eyelashes through a micro-surgical transplant procedure - doing away with the need for false eyelashes. The micro-surgical eyelash transplant procedure is only available in the UK, by Transform and marks an important landmark in permanent treatment of Madarosis - the medical term for eyelash loss. The procedure takes approximately four hours and is done under local anaesthetic. It begins by taking a hair graft from the back of the head and then by dissecting it under a microscope, it is placed into tiny incisions in the eyelid.